Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Nationwide Ventures is the corporate venture capital arm of Nationwide and invests in early-stage startups focused primarily on insurance and financial services innovation. The organization backs companies working in areas such as analytics, automation, fintech, insurtech, and related digital platforms, and it also evaluates new technologies and business models for strategic relevance to Nationwide. While some sources mention exposure to healthtech, Nationwide Ventures is not itself a biotechnology, pharmaceutical, or healthcare operating company. It does not appear to develop therapeutic products or maintain a drug pipeline; instead, it functions as a strategic investor aligned with Nationwide\u2019s broader insurance and financial services business.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Nationwide Ventures.